The impact of chronic kidney disease on medication choice and pharmacologic management in patients with heart failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The impact of chronic kidney disease on medication choice and pharmacologic management in patients with heart failure

Published:2018-06-03 Issue:6 Volume:11 Page:571-579
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Shah Syed Raza¹,Winchester David E²

Affiliation:

1. Department of Internal Medicine, North Florida Regional Medical Center, University of Central Florida (Gainesville), Gainesville, FL, USA

2. Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2018.1479252

Reference100 articles.

1. Heart Disease and Stroke Statistics—2007 Update

2. Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden?

3. Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference

4. Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ICNP® terminology subset for people with chronic kidney disease under conservative treatment;Acta Paulista de Enfermagem;2023-08-09

2. Subconjunto terminológico CIPE® para pessoas com doença renal crônica em tratamento conservador;Acta Paulista de Enfermagem;2023

3. Eplerenone inhibits the macrophage-to-myofibroblast transition in rats with UUO-induced type 4 cardiorenal syndrome through the MR/CTGF pathway;International Immunopharmacology;2022-12

4. Advance Care Planning Documentation and Intensity of Care at the End of Life for Adults With Congestive Heart Failure, Chronic Kidney Disease, and Both Illnesses;Journal of Pain and Symptom Management;2022-02

5. Inhibition of CYP1B1 ameliorates cardiac hypertrophy induced by uremic toxin;Molecular Medicine Reports;2019-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3